152 related articles for article (PubMed ID: 10455267)
1. The antiplatelet activity of PMC, a potent alpha-tocopherol analogue, is mediated through inhibition of cyclo-oxygenase.
Sheu JR; Lee CR; Lin CC; Kan YC; Lin CH; Hung WC; Lee YM; Yen MH
Br J Pharmacol; 1999 Jul; 127(5):1206-12. PubMed ID: 10455267
[TBL] [Abstract][Full Text] [Related]
2. Thromboxane (Tx) A2 receptor blockade and TxA2 synthase inhibition alone and in combination: comparison of anti-aggregatory efficacy in human platelets.
Watts IS; Wharton KA; White BP; Lumley P
Br J Pharmacol; 1991 Feb; 102(2):497-505. PubMed ID: 1826620
[TBL] [Abstract][Full Text] [Related]
3. Mechanisms involved in the antiplatelet effect of C-phycocyanin.
Chiu HF; Yang SP; Kuo YL; Lai YS; Chou TC
Br J Nutr; 2006 Feb; 95(2):435-40. PubMed ID: 16469164
[TBL] [Abstract][Full Text] [Related]
4. Morphine-potentiated agonist-induced platelet aggregation through alpha2-adrenoceptors in human platelets.
Sheu JR; Yeh GC; Fang CL; Lin CH; Hsiao G
J Cardiovasc Pharmacol; 2002 Nov; 40(5):743-50. PubMed ID: 12409983
[TBL] [Abstract][Full Text] [Related]
5. Inhibitory mechanisms of metallothionein on platelet aggregation in in vitro and platelet plug formation in in vivo experiments.
Sheu JR; Hsiao G; Shen MY; Wang Y; Lin KH; Lin CH; Chou DS
Exp Biol Med (Maywood); 2003 Dec; 228(11):1321-8. PubMed ID: 14681547
[TBL] [Abstract][Full Text] [Related]
6. Mechanism of inhibition of platelet aggregation by HCL-31D.
Chou TC; Li CY; Lee AR; Wu TM
Eur J Pharmacol; 2000 Jan; 387(2):125-31. PubMed ID: 10650152
[TBL] [Abstract][Full Text] [Related]
7. Mechanisms involved in the antiplatelet activity of ketamine in human platelets.
Chang Y; Chen TL; Wu GJ; Hsiao G; Shen MY; Lin KH; Chou DS; Lin CH; Sheu JR
J Biomed Sci; 2004; 11(6):764-72. PubMed ID: 15591773
[TBL] [Abstract][Full Text] [Related]
8. The inhibitory effect of 2-thienyl 2'-hydroxyphenyl ketone (C85) on platelet thromboxane formation.
Chou TC; Hsu LY; Yen MH; Ding YA
Thromb Res; 1996 Oct; 84(2):83-95. PubMed ID: 8897698
[TBL] [Abstract][Full Text] [Related]
9. An antithrombotic agent, NQ301, inhibits thromboxane A2 receptor and synthase activity in rabbit platelets.
Jin YR; Cho MR; Lee KS; Lee JJ; Lim Y; Han XH; Oh KW; Hong JT; Yoo HS; Yun YP
Basic Clin Pharmacol Toxicol; 2005 Sep; 97(3):162-7. PubMed ID: 16128910
[TBL] [Abstract][Full Text] [Related]
10. alpha-Naphthoflavone, a potent antiplatelet flavonoid, is mediated through inhibition of phospholipase C activity and stimulation of cyclic GMP formation.
Hsiao G; Chang CY; Shen MY; Chou DS; Tzeng SH; Chen TF; Sheu JR
J Agric Food Chem; 2005 Jun; 53(13):5179-86. PubMed ID: 15969494
[TBL] [Abstract][Full Text] [Related]
11. Antiplatelet effect of marchantinquinone, isolated from Reboulia hemisphaerica, in rabbit washed platelets.
Liao CH; Ko FN; Wu CL; Teng CM
J Pharm Pharmacol; 2000 Mar; 52(3):353-9. PubMed ID: 10757426
[TBL] [Abstract][Full Text] [Related]
12. Comparison of the relative activities of alpha-tocopherol and PMC on platelet aggregation and antioxidative activity.
Sheu JR; Lee CR; Hsiao G; Hung WC; Lee YM; Chen YC; Yen MH
Life Sci; 1999; 65(2):197-206. PubMed ID: 10416825
[TBL] [Abstract][Full Text] [Related]
13. Mechanisms involved in the antiplatelet activity of Staphylococcus aureus lipoteichoic acid in human platelets.
Sheu JR; Lee CR; Lin CH; Hsiao G; Ko WC; Chen YC; Yen MH
Thromb Haemost; 2000 May; 83(5):777-84. PubMed ID: 10823277
[TBL] [Abstract][Full Text] [Related]
14. Inhibition on platelet activation by shikonin derivatives isolated from Arnebia euchroma.
Ko FN; Lee YS; Kuo SC; Chang YS; Teng CM
Biochim Biophys Acta; 1995 Sep; 1268(3):329-34. PubMed ID: 7548232
[TBL] [Abstract][Full Text] [Related]
15. Mechanisms involved in the antiplatelet activity of magnesium in human platelets.
Sheu JR; Hsiao G; Shen MY; Fong TH; Chen YW; Lin CH; Chou DS
Br J Haematol; 2002 Dec; 119(4):1033-41. PubMed ID: 12472585
[TBL] [Abstract][Full Text] [Related]
16. Mechanisms of antiplatelet activity of PC-09, a newly synthesized pyridazinone derivative.
Cherng SC; Huang WH; Shiau CY; Lee AR; Chou TC
Eur J Pharmacol; 2006 Feb; 532(1-2):32-7. PubMed ID: 16457809
[TBL] [Abstract][Full Text] [Related]
17. Mechanisms involved in the antiplatelet activity of midazolam in human platelets.
Sheu JR; Hsiao G; Luk HN; Chen YW; Chen TL; Lee LW; Lin CH; Chou DS
Anesthesiology; 2002 Mar; 96(3):651-8. PubMed ID: 11873041
[TBL] [Abstract][Full Text] [Related]
18. Antiplatelet activity of [5-(2-methoxy-5-chlorophenyl)furan-2-ylcarbonyl]guanidine (KR-32570), a novel sodium/hydrogen exchanger-1 and its mechanism of action.
Lee KS; Park JW; Jin YR; Jung IS; Cho MR; Yi KY; Yoo SE; Chung HJ; Yun YP; Park TK; Shin HS
Arch Pharm Res; 2006 May; 29(5):375-83. PubMed ID: 16756082
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of cyclooxygenase activity and increase in platelet cyclic AMP by girinimbine, isolated from Murraya euchrestifolia.
Ko FN; Lee YS; Wu TS; Teng CM
Biochem Pharmacol; 1994 Jul; 48(2):353-60. PubMed ID: 8053931
[TBL] [Abstract][Full Text] [Related]
20. Difference of (Ca2+)i movements in platelets stimulated by thrombin and TRAP: the involvement of alpha(IIb)beta3-mediated TXA2 synthesis.
Aoki T; Tomiyama Y; Honda S; Senzaki K; Tanaka A; Okubo M; Takahashi F; Takasugi H; Seki J
Thromb Haemost; 1998 Jun; 79(6):1184-90. PubMed ID: 9657446
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
